Related Experiment Video
Updated: Nov 29, 2025

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Evidence of evolution towards left midventricular obstruction in severe Anderson-Fabry cardiomyopathy
Francesca Graziani1, Rosa Lillo2, Elena Panaioli2
1Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Insights
Fabry cardiomyopathy can progress to a midventricular obstructive form in men with severe left ventricular hypertrophy (LVH). This occurs even with timely enzyme replacement therapy, suggesting a potential adverse disease outcome.
Area of Science:
- Cardiology
- Genetics
- Rare Diseases
Background:
- Fabry cardiomyopathy is a genetic disorder causing progressive cardiac damage.
- Left ventricular outflow tract obstruction is a rare complication, often mimicking hypertrophic cardiomyopathy.
- Severe left ventricular hypertrophy (LVH) is a hallmark of advanced Fabry cardiomyopathy.
Purpose of the Study:
- To investigate the evolution of cardiac phenotype in Fabry disease patients.
- To identify specific patterns of LVH leading to left ventricular outflow tract obstruction.
- To describe a newly observed midventricular obstructive form of Fabry cardiomyopathy.
Main Methods:
- Case series of three classically affected male patients with Fabry disease.
- Analysis of cardiac imaging to assess left ventricular hypertrophy (LVH) and obstruction.
- Evaluation of disease progression despite enzyme replacement therapy.
Main Results:
- All patients developed a midventricular obstructive phenotype over time.
- Massive LVH involving papillary muscles was the primary cause of obstruction.
- This obstruction pattern differed from typical hypertrophic cardiomyopathy.
Conclusions:
- Fabry cardiomyopathy can evolve into a midventricular obstructive form.
- This progression is linked to significant diagnostic delay and severe LVH prior to treatment.
- The midventricular obstructive phenotype may represent an adverse outcome of Fabry disease.
Aims:
In Fabry cardiomyopathy, left ventricular outflow tract obstruction mimicking hypertrophic cardiomyopathy is a very rare finding, with few cases reported and successfully treated with cardiac surgery. In our population of patients with Fabry disease and severe left ventricular hypertrophy (LVH) at the time of diagnosis, we observed an evolution towards a midventricular obstructive phenotype.
Methods And Results:
We present a case series of three classically affected Fabry male patients with significant diagnostic delay and severe cardiac involvement (maximal wall thickness >20 mm) at first evaluation. All patients developed midventricular obstructive form over time despite prompt initiation and optimal compliance to enzyme replacement therapy. The extension and distribution of the LVH, involving the papillary muscles, was the main mechanism of obstruction, unlike the asymmetric septal basal hypertrophy and the mitral valve abnormalities commonly seen as substrate of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Conclusions:
Fabry cardiomyopathy can evolve over time towards a midventricular obstructive form due to massive LVH in classically affected men with significant diagnostic delay and severe LVH before enzyme replacement therapy initiation. This newly described cardiac phenotype could represent an adverse outcome of the disease.
More Related Videos
10:33Assessment of Right Ventricular Structure and Function in Mouse Model of Pulmonary Artery Constriction by Transthoracic Echocardiography
Published on: February 3, 2014
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Cardiomyopathy I: Introduction and Classification